Please login to the form below

Not currently logged in
Email:
Password:

Compassionate use programme

This page shows the latest Compassionate use programme news and features for those working in and with pharma, biotech and healthcare.

Gilead reports remdesivir cuts risk of death in severe COVID-19 patients

Gilead reports remdesivir cuts risk of death in severe COVID-19 patients

Also reveals new analyses from compassionate use programme. In new data released detailing the efficacy of Gilead’s investigational antiviral remdesivir, the drug reduced the risk of death by 62% in ... Gilead also revealed new analyses from its

Latest news

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    compassionate use requests for the drug following an overwhelming demand for the drug. ... Although the compassionate use programme now only extends to children and pregnant women, Gilead said the ‘expanded access’ programme will allow hospitals or

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Just Treatment is also urging the UK government to override Vertex’s patent via compulsory licensing or Crown Use Licence. ... It also stressed that it is continuing to provide free medicines to the most seriously ill patients through its compassionate

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics